Advertisement

Phytothérapie

, Volume 8, Issue 2, pp 124–128 | Cite as

Huile de nigelle cultivée, Nigella sativa L. (Ranunculaceae)

  • K. Ghedira
  • R. Le Jeune
Formation Continue Matière Médicale Pratique

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliographie

  1. 1.
    Abdel Fatah M, Matsumoto K, Watanabe H (2000) Antinociceptive effects of Nigella sativa oil and its major components in mice. Eur J Pharmacol 400:89–97CrossRefGoogle Scholar
  2. 2.
    Abdel-Wahhab MA, Aly SE (2005) Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (glove) in rats during aflatoxicosis. J Appl Toxicol 25:218–223CrossRefPubMedGoogle Scholar
  3. 3.
    Agrawal R, Kharya MD, Shrivastava R (1979) Antimicrobial and anthelmintic activities of the essential oil of Nigella sativa Linn. Indian J Exp Biol 17:1264–1265Google Scholar
  4. 4.
    Ahmed MS, Honda G, Miki W (1979) Herbs and herbalists in the Middle East. Institute for the study of languages and cultures of Asia and Africa, TokyoGoogle Scholar
  5. 5.
    Ali BH, Blunden G (2003) Pharmacological and toxicological properties of Nigella sativa. Phytotherapy Res 17:299–305CrossRefGoogle Scholar
  6. 6.
    Aljabre SHM, Randhawa MA, Akhtar N, et al (2005) Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J Ethnopharmacol 101:116–119CrossRefPubMedGoogle Scholar
  7. 7.
    Al Mosawi A (2007) Therapeutic potential of natural plant and dietary constituents (section 1): Nigella sativa. In: “Nutrition research advances” Sarah V. Watkins. Nova Science Publishers, New YorkGoogle Scholar
  8. 8.
    Al-Saleh IA, Billedo G, El-Doush II (2006) Levels of selenium, DL-α-tocopherol, DL-β-tocopherol, all-trans-retinol, thymoquinone and thymol in different brands of Nigella sativa seeds. J Food Compos Anal 19:167–175CrossRefGoogle Scholar
  9. 9.
    Baser KHC, Honda G, Miki W (1986) Herb drugs and herbalists in Turkey. Institute for the study of languages and cultures of Asia and Africa, TokyoGoogle Scholar
  10. 10.
    Bellakhdar J (1997) La pharmacopée marocaine traditionnelle. Ibis Press, ParisGoogle Scholar
  11. 11.
    Bouquet J (1921) Matière médicale indigène de l’Afrique du Nord. Trav. Off. Nat. Matières premières végétales. Notice 8:1–29Google Scholar
  12. 12.
    Burits M, Bucar F (2000) Antioxidant activity of Nigella sativa essential oil. Phytother Res 14:323–328CrossRefPubMedGoogle Scholar
  13. 13.
    Cheikh-Rouhou S, Besbes S, Hentati B, et al (2007) Nigella sativa L.: chemical composition and physicochemical characteristics of lipid fraction. Food Chem 101:673–681CrossRefGoogle Scholar
  14. 14.
    Ducros AH (1930) Essai sur le droguier populaire arabe de l’Inspectorat des pharmacies du Caire. Mém Inst Egypte 15:166Google Scholar
  15. 15.
    EI-Dakhakhny M, Barakat M, Abd EI-Halim, et al (2000) Effect of Nigella sativa oil on gastric secretion and ethanol induced ulcer in rats. J Ethnopharmacol 72:299–304CrossRefGoogle Scholar
  16. 16.
    EI-Dakhakhny M, Mady NI, Halim MA (2000) Nigella sativa L. protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittelforsch 50:832–836Google Scholar
  17. 17.
    El-Dakhakhny M, Mady NI, Lembert N, et al (2002) The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 65:465–466CrossRefGoogle Scholar
  18. 18.
    El-Dakhakhny M, Mady NI, Lembert N, et al (2002) Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol 81(2):161–164CrossRefPubMedGoogle Scholar
  19. 19.
    El-Saleh SC, Al-Sagair OA, Al-Khalaf MI (2004) Thymoquinone and Nigella sativa oil protection against methionine-induced hyperhomocysteinemia in rats. Int J Cardiol 93:19–23CrossRefPubMedGoogle Scholar
  20. 20.
    Ghosheh OA, Houdi AA, Crooks PA (1999) High performance liquid chromatographic analysis of the pharmacologically active quinines and related compounds in the oil of the black seed (Nigella sativaL.). J Pharm Biomed Anal 19(5):757–762CrossRefPubMedGoogle Scholar
  21. 21.
    Gilani AH, Jabeen Q, Khan MAU (2004) A review of medecinal uses and pharmacological activites of Nigella sativa. Pak J Biol Sci 7:441–451CrossRefGoogle Scholar
  22. 22.
    Goreja WG (2003) Black Seed: Nature’s Miracle Remedy. Amazing Herbs Press, New York, NYGoogle Scholar
  23. 23.
    Hajhashemi V, Ghannadi A, Jafarabadi H (2004) Black cumin seed essential oil, as a potent analgesic and anti-inflammatory drug. Phytother Res 18(3):195–199CrossRefPubMedGoogle Scholar
  24. 24.
    Hegnauer R (1973) Chemotaxonomie der pflanzen. Birkhauser Verlag, Basel/Stutgart, p. 43Google Scholar
  25. 26.
    Houdi AA, Crooks PA (1999) High performance liquid chromatographic analysis of the pharmacologically active quinines and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal 19(5):757–762CrossRefPubMedGoogle Scholar
  26. 27.
    Houghton PJ, Zarka R, de las Heras B, et al (1995) Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61:33–36CrossRefPubMedGoogle Scholar
  27. 28.
    Ilhan A, Gurel A, Armutcu F, et al (2005) Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology 49:456–464CrossRefPubMedGoogle Scholar
  28. 29.
    Kanter M, Demir H, Karakaya C, Ozbek H (2005) Gastroprotective activity of Nigella sativa L. oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol 11(42):6662–6666 Site web: http://www.uni-graz.at/~Ekatzer/engl/Nige_sat.html.PubMedGoogle Scholar
  29. 30.
    Khanna T, Zaidi FA, Dandiya PC (1993) CNS and analgesic studies on Nigella sativa. Fitoterapia 5:407–410Google Scholar
  30. 31.
    Kökdil G, Yilmaz H (2005) Analysis of the fixed oils of the genus Nigella L. (Ranunculaceae) in Turkey. Biochem Syst Ecol 33:1203–1209CrossRefGoogle Scholar
  31. 32.
    Lautenbacher LM (1997) Schwarzkümmelöl. Dtsch Apoth Ztg 137:68–69Google Scholar
  32. 33.
    Mahmoud MR, EI-Abhar HS, Saleh S (2002) The effects of Nigella sativa oil against the liver damage induced by Schistosoma mansonii mice. J Ethnopharmacol 79:1–11CrossRefPubMedGoogle Scholar
  33. 34.
    Morsi NM (2000) Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol Pol 49:63–74PubMedGoogle Scholar
  34. 35.
    Nagi MM, Alam K, Badary OA (1999) Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 47:143–159Google Scholar
  35. 36.
    Nair SC, Salomi MJ, Panikkar B, et al (1991) Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. J Ethnopharmacol 31:16–20CrossRefGoogle Scholar
  36. 37.
    Nair MKM, Vasudevan P, Venkitanarayanan K (2005) Antibacterial effect of black seed oil on Listeria monocytogenes. Food Control 16:395–398CrossRefGoogle Scholar
  37. 38.
    Nickavar B, Mojab F, Javidnia K, Amoli MAR (2003) Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran Z. Naturforsch 58c:629–631Google Scholar
  38. 39.
    Padhye S, Banerjee S, Ahmad A, et al (2008) From here to eternity: the secret of Pharaohs: therapeutic potential of black cumin seeds and beyond. Cancer Ther 6:495–510PubMedGoogle Scholar
  39. 40.
    Ramadan MF, Mörsel JT (2003) Analysis of glycolipids from black cumin (Nigella sativa L.), coriander (Coriandrum sativum L.) and niger (Guizotia abyssinica Cass.) oil seeds. Food Chem 80:197–204CrossRefGoogle Scholar
  40. 41.
    Salem ML, Hossain MS (2000) Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int J Immunopharmacol 22:729–740CrossRefPubMedGoogle Scholar
  41. 42.
    Salem ML (2005) Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 5:1749–1770CrossRefPubMedGoogle Scholar
  42. 43.
    Salih B, Sipahi T, Dönmez EO (2009) Ancient Nigella seeds from Boyali Höyük in north-central Turkey, J. Ethnopharmacol 124(3): 416–420CrossRefPubMedGoogle Scholar
  43. 44.
    Sayed MD (1980) Traditional medicine in health care. J Ethnopharmacol 2:19–22CrossRefPubMedGoogle Scholar
  44. 45.
    Schleicher P, Saleh M (1998) Black seed cumin: the magical Egyptian herb for allergies, asthma, and immune disorders. Healing Arts Press, Rochester, Vermont, p 90Google Scholar
  45. 46.
    Sijelmassi A (1991) Les plantes médicinales du Maroc. Le Fennec, CasablancaGoogle Scholar
  46. 47.
    Wichtl M, Anton R (2003) Plantes thérapeutiques. Tec & Doc Lavoisier/EMI, Paris, 416–417Google Scholar
  47. 48.
    Worthen DR, Ghosheh OA, Crooks PA (1998) The in vitro anti-tumour activity of some crude and purified components of black seed, Nigella sativa L. Anticancer Res 18:1527–1532PubMedGoogle Scholar
  48. 49.
    Zaoui A, Cherrah Y, Alaoui K et al (2002) Effects of Nigella sativa fixed oil on blood homeostasis in rat. J Ethnopharmacol 79:23–26CrossRefPubMedGoogle Scholar
  49. 50.
    Zaoui A, Cherrah Y, Mahassine N, et al (2002) Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 9:69–74CrossRefPubMedGoogle Scholar

Copyright information

© Springer Verlag 2010

Authors and Affiliations

  • K. Ghedira
    • 1
    • 2
  • R. Le Jeune
    • 3
  1. 1.Dumenat de phytothérapieParis-XIIIBobigny cedexFrance
  2. 2.Laboratoire de pharmacognosiefaculté de pharmacie de MonastirMonastirTunisie
  3. 3.Boussy-Saint-AntoineFrance

Personalised recommendations